Vaxcyte Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	6,604	5,976	3,787	1,256	1,354	-	-
Market Cap Growth	-	57.79%	201.58%	-7.24%	-	-	-
Enterprise Value	5,553	4,925	2,874	1,027	968	-59	-66
PE Ratio	-14.85	-14.85	-16.95	-12.55	-15.17	-	-
PB Ratio	5.32	4.82	3.97	4.42	3.91	-	-
P/FCF Ratio	-16.39	-16.39	-21.46	-9.82	-28.36	-	-
P/OCF Ratio	-20.13	-20.13	-22.20	-10.34	-29.03	-	-
EV/EBITDA Ratio	-12.56	-12.56	-13.41	-10.63	-11.02	1.20	2.32
EV/EBIT Ratio	-12.24	-12.24	-12.86	-10.26	-10.85	1.17	2.24
EV/FCF Ratio	-13.50	-13.50	-16.29	-8.02	-20.27	1.22	2.05
Debt / Equity Ratio	0.02	0.02	0.02	0.06	-	-	0.00
Debt / EBITDA Ratio	-0.07	-0.07	-0.08	-0.17	-	-	-0.01
Debt / FCF Ratio	-0.08	-0.08	-0.10	-0.13	-	-	0.00
Quick Ratio	7.43	7.43	22.98	8.57	8.24	5.34	9.85
Current Ratio	7.54	7.54	23.26	8.93	8.30	5.59	9.93
Interest Coverage	-	-	-111741.50	-14295.71	-12744.29	-1255.85	-392.13
Return on Equity (ROE)	-32.00%	-32.00%	-43.80%	-32.40%	-37.20%	61.30%	-
Return on Assets (ROA)	-29.70%	-29.70%	-40.00%	-28.20%	-25.90%	-73.70%	-
Return on Capital (ROIC)	-36.86%	-36.86%	-23.91%	-34.46%	-25.90%	50.91%	61.72%
Earnings Yield	-6.09%	-6.73%	-5.90%	-7.97%	-6.59%	-	-
FCF Yield	-5.52%	-6.10%	-4.66%	-10.19%	-3.53%	-	-
Buyback Yield / Dilution	-49.75%	-49.75%	-24.95%	-75.73%	-678.53%	-4.55%	-
Total Shareholder Return	-49.75%	-49.75%	-24.95%	-75.73%	-678.53%	-4.55%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).